2022
What’s in a Name? Terminology Preferences Among Patients Receiving Methadone Treatment
Gazzola MG, Maclean E, Beitel M, Carmichael ID, Cammack KM, Eggert KF, Roehrich T, Madden LM, Jegede O, Zheng X, Bergman E, Barry DT. What’s in a Name? Terminology Preferences Among Patients Receiving Methadone Treatment. Journal Of General Internal Medicine 2022, 38: 653-660. PMID: 36163526, PMCID: PMC9971370, DOI: 10.1007/s11606-022-07813-w.Peer-Reviewed Original ResearchConceptsOpioid use disorderSubstance use disordersMethadone treatmentUse disordersOutpatient methadone treatment programMethadone treatment programsPresenting problemPreferences of patientsTerminology preferencesSubstance-dependent personsCross-sectional surveyAdult patientsMean ageUnivariate analysisMain MeasuresParticipantsPatientsTreatment programKey ResultsWeSubstance abuseSubstance useDisordersSignificant differencesTreatmentDemographic differencesAddiction counselors
2020
Patterns of Vitamin D Deficiency in a Community Outpatient Psychiatric Practice: a Real-World Evaluation of Treatment Gaps
Jegede O, Gayam V, Gunasekara R, Tiongson B, Ishola A, Sidhu J, Virk J, Virk I, Ahmed S, Ojo O, Ojimba C, Ogunlesi C, Olupona T. Patterns of Vitamin D Deficiency in a Community Outpatient Psychiatric Practice: a Real-World Evaluation of Treatment Gaps. Psychiatric Quarterly 2020, 91: 561-570. PMID: 32086668, DOI: 10.1007/s11126-020-09720-x.Peer-Reviewed Original ResearchConceptsVitamin D deficiencyVitamin D deficiency treatmentClinical practice guidelinesD deficiencyVitamin DEndocrine Society Clinical Practice GuidelineDeficient vitamin D levelsVitamin D supplementation practicesOutpatient mental health clinicPhysician prescription practicesVitamin D levelsVitamin D supplementationMajority of patientsVitamin D metabolismCommunity teaching hospitalConsecutive psychiatric outpatientsMental health clinicsOutpatient psychiatric practiceAfrican AmericansD supplementationOutpatient psychiatristsD metabolismPrescription practicesD levelsTreatment gap
2019
Outcomes of Direct-Acting Antiviral Treatment of Psychiatric Patients with Comorbid Hepatitis C Virus Infection
Gayam V, Jegede O, Tiongson B, Mandal AK, Sidhu J, Garlapati P. Outcomes of Direct-Acting Antiviral Treatment of Psychiatric Patients with Comorbid Hepatitis C Virus Infection. Digestive Diseases 2019, 38: 232-239. PMID: 31494648, DOI: 10.1159/000502514.Peer-Reviewed Original ResearchConceptsHepatitis C virus infectionC virus infectionNon-psychiatric patientsPsychiatric patientsPsychiatric diagnosisAntiviral treatmentVirus infectionTreatment responsePsychiatric disordersComorbid hepatitis C virus (HCV) infectionDirect-acting antiviral treatmentRetrospective cohort observational studyComorbid substance use disorderNeuropsychiatric adverse effectsPrior treatment statusSustained virologic responseCohort observational studyPrimary psychiatric diagnosisComorbid substance abusePrimary care practicesSubstance use disordersHCV patientsVirologic responseHigh burdenObservational studyRisperidone-Associated Atrioventricular Block
Jegede O, Taher K. Risperidone-Associated Atrioventricular Block. American Journal Of Therapeutics 2019, Publish Ahead of Print: &na;. PMID: 29927774, DOI: 10.1097/mjt.0000000000000810.Peer-Reviewed Original Research